development [phsf]
Method [inpr]
Combined [qlco]
Tablet [bodm]
Formulation [resa]
atorvastatin [orch, phsu]
ezetimibe [orch, phsu]
RP [gngm]
Method [inpr]
Pharmaceutical Preparations [phsu]
ezetimibe [orch, phsu]
atorvastatin [orch, phsu]
To [qlco]
Lipid level [lbtr]
Blood [tisu]
Decrease [qlco]
secondary [neop]
Events [evnt]
Patients [podg]
high cholesterol [fndg]
Clinical [qlco]
Cardiovascular disease [dsyn]
Non [ftcn]
Fatal [qlco]
Fatal [qlco]
Heart attack [dsyn]
Pharmacopoeia [inpr]
Method [inpr]
Available [ftcn]
Testing [ftcn]
Recommended [idcn]
FDA [hcro]
development [phsf]
Test [lbpr]
Method [inpr]
Very [qlco]
Critical [qlco]
Parameter [spco]
Pharmaceutical Preparations [phsu]
Class II [inpr]
Drugs [phsu]
Slightly [idcn]
soluble [celc]
Good [qlco]
Permeable [ftcn]
PROPOSED [idcn]
Method [inpr]
effects [qlco]
[pH] [qnco]
Surfactant [bacs, lipd, phsu]
Poorly [qlco]
water therapy [topp]
soluble [celc]
Combined [qlco]
Drug [phsu]
Different [qlco]
Values [qlco]
In Vitro [inpr]
Environment [spco]
investigated [ftcn]
Content [menp]
Study [mnob]
Design [acty]
To [qlco]
Answer [inpr]
Open-ended [qlco]
Question [inpr]
Test conditions [qlco]
sink [mnob]
condition [dsyn]
USP [moft]
apparatus [mnob]
Rotation [ftcn]
Speed [qnco]
rpm [qnco]
M NOS [aapp, imft]
Acetate [orch, phsu]
Buffer [irda, phsu]
[pH] [qnco]
Containing [ftcn]
SDS [gngm]
Medium [inpr]
Quantification [qnco]
Sample [sbst]
Analyzed [resa]
New [tmco]
RP [gngm]
Method [inpr]
UV [npop]
Detection [topp]
NM [celf]
